Pure Global
NCT06354504

Bactericidal Permeability Protein Inhibitor and Interleukin-1beta Levels After Non-surgical Periodontal Treatment

Gingival Crevicular Fluid (GCF) Bactericidal/Permeability-increasing Protein (BPI) and Interleukin (IL)-1beta in Periodontitis Patients: Non-surgical Periodontal Treatment Effects
Akdeniz University·ClinicalTrials.gov·procedureCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Periodontitis
Drug/Device/Intervention
Non-surgical periodontal treatment
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Akdeniz University
Location
Antalya,Antalya, Turkey
Timeline & enrollment
Phase
N/A
Start date
Nov 19, 2019
End date
Sep 20, 2020
Enrollment
30 participants
Primary outcome

Gingival crevicular fluid Bactericidal/permeability-increasing proteins levels

Summary

The aim of this study was to examine the relationship between healing response after
 non-surgical periodontal treatment and baseline gingival crevicular fluid (GCF) levels of
 bactericidal/permeability-increasing protein (BPI) and interleukin-1beta (IL-1ß).

ICD-10 classifications
Chronic periodontitisPeriodontosisAcute periodontitisChronic apical periodontitisPeriodontal disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06354504
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06354504 through Pure Global AI's free database. This phase not specified trial is sponsored by Akdeniz University and is currently Completed. The study focuses on Periodontitis. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.